9674 Federal Register / Vol. 72, No. 42 / Monday, March 5, 2007 / Rules and Regulations 

TABLE 4.—ALL TEMPORARY REVISIONS INCORPORATED BY REFERENCE—Continued 

Temporary revision— Dated— To the—

Canadair Regional Jet Temporary Revision RJ/152–5 .......... October 3, 2006 ..... Canadair Regional Jet Airplane Flight Manual, CSP A–012. 

Canadair Regional Jet Temporary Revision RJ/152–6 .......... January 26, 2007 ... Canadair Regional Jet Airplane Flight Manual, CSP A–012. 

(1) The Director of the Federal Register 

approved the incorporation by reference of 

the temporary revisions listed in Table 5 of 

this AD in accordance with 5 U.S.C. 552(a) 

and 1 CFR part 51. 

TABLE 5.—NEW TEMPORARY REVISIONS INCORPORATED BY REFERENCE

Temporary revision— Dated— To the—

Canadair Challenger Temporary Revision 604/21–2 ............. January 30, 2007 ... Canadair Challenger CL–604 Airplane Flight Manual, PSP 

604–1. 

Canadair Regional Jet Temporary Revision RJ/152–6 .......... January 26, 2007 ... Canadair Regional Jet Airplane Flight Manual, CSP A–012. 

(2) On November 14, 2006 (71 FR 63219, 

October 30, 2006), the Director of the Federal 

Register approved the incorporation by 

reference of Bombardier Alert Service 

Bulletin A604–27–029, dated September 28, 

2006; Bombardier Service Bulletin 601R–27–

147, dated September 28, 2006; Bombardier 

Modification Summary Package 

IS601R27410051, Revision C, dated 

September 29, 2006; and the temporary 

revisions listed in Table 6 of this AD in 

accordance with 5 U.S.C. 552(a) and 1 CFR 

part 51. 

TABLE 6.—PREVIOUS TEMPORARY REVISIONS INCORPORATED BY REFERENCE

Temporary revision— Dated— To the—

Canadair Challenger Temporary Revision 604/21–1 ............. October 3, 2006 ..... Canadair Challenger CL–604 Airplane Flight Manual, PSP 

604–1. 

Canadair Regional Jet Temporary Revision RJ/152–5 .......... October 3, 2006 ..... Canadair Regional Jet Airplane Flight Manual, CSP A–012. 

(3) On July 30, 1998 (63 FR 34574, June 25, 

1998), the Director of the Federal Register 

approved the incorporation by reference of 

Bombardier Service Bulletin S.B. 601R–27–

053, Revision B, dated February 21, 1997; in 

accordance with 5 U.S.C. 552(a) and 1 CFR 

part 51. 

(4) Contact Bombardier, Inc., Canadair, 

Aerospace Group, P.O. Box 6087, Station 

Centre-ville, Montreal, Quebec H3C 3G9, 

Canada, for a copy of this service 

information. You may review copies at the 

FAA, Transport Airplane Directorate, 1601 

Lind Avenue, SW., Renton, Washington; or at 

the National Archives and Records 

Administration (NARA). For information on 

the availability of this material at NARA, call 

202–741–6030, or go to: http:// 

www.archives.gov/federal-register/cfr/ibrlocations.html. 

Issued in Renton, Washington, on February 

21, 2007. 

Ali Bahrami, 

Manager, Transport Airplane Directorate, 

Aircraft Certification Service. 

[FR Doc. E7–3661 Filed 3–2–07; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Part 14 

Advisory Committee: Change of Name 

and Function 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Final rule. 

SUMMARY: The Food and Drug 

Administration (FDA) is amending the 

standing advisory committees’

regulations to change the name and 

function of the Advisory Committee for 

Pharmaceutical Science. This action is 

being taken to reflect changes made to 

the charter for this advisory committee. 

DATES: This rule is effective March 5, 

2007. 

FOR FURTHER INFORMATION CONTACT: 

Theresa Green, Committee Management 

Officer (HF–4), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–1220. 

SUPPLEMENTARY INFORMATION: FDA is 

announcing that the name of the 

Advisory Committee for Pharmaceutical 

Science, which was established on 

January 22, 1990, has been changed. The 

name Advisory Committee for 

Pharmaceutical Science and Clinical 

Pharmacology more accurately describes 

the subject areas for which the 

committee is responsible. The 

committee shall provide advice on 

scientific, clinical and technical issues 

related to safety and effectiveness of 

drug products for use in the treatment 

of a broad spectrum of human diseases, 

the quality characteristics which such 

drugs purport or are represented to have 

and as required, any other product for 

which FDA has regulatory 

responsibility, and make appropriate 

recommendations to the Commissioner 

of Food and Drugs. The Committee may 

also review agency sponsored 

intramural and extramural biomedical 

research programs in support of FDA’s 

drug regulatory responsibilities and its 

critical path initiatives related to 

improving the efficacy and safety of 

drugs and improving the efficiency of 

drug development. 

FDA is revising § 14.100(c)(16) (21 

CFR 14.100(c)(16)) to reflect these 

changes. In this document, FDA is 

hereby formally changing the name and 

the function of the committee by 

revising § 14.100(c)(16). Publication of 

this final rule constitutes a final action 

on this change under the Administrative 

Procedure Act. Under 5 U.S.C. 553(b)(B) 


erjones on PRODPC74 with RULES
Federal Register / Vol. 72, No. 42 / Monday, March 5, 2007 / Rules and Regulations 9675 

and (d) and 21 CFR 10.40(d) and (e), the 

agency finds good cause to dispense 

with notice and public procedure and to 

proceed to an immediately effective 

regulation. Such notice and procedures 

are unnecessary and are not in the 

public interest, because the final rule is 

merely codifying the new name and 

expanded function of the advisory 

committee to reflect the current 

committee charter. 

List of Subjects in 21 CFR Part 14 

Administrative practice and 

procedure, Advisory committees, Color 

additives, Drugs, Radiation protection. 

■ Therefore, under the Federal Food, 

Drug, and Cosmetic Act and under 

authority delegated to the Commissioner 

of Food and Drugs, 21 CFR part 14 is 

amended as follows: 

PART 14—PUBLIC HEARING BEFORE 

A PUBLIC ADVISORY COMMITTEE 

■ 1. The authority citation for 21 CFR 

part 14 continues to read as follows: 

Authority: 5 U.S.C. App. 2; 15 U.S.C. 

1451–1461, 21 U.S.C. 41–50, 141–149, 321–

394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42 

U.S.C. 201, 262, 263b, 264; Pub. L. 107–109; 

Pub. L. 108–155. 

■ 2. Section 14.100 is amended by 

revising the heading of paragraph (c)(16) 

and paragraph (c)(16)(ii) to read as 

follows: 

§ 14.100 List of standing advisory 

committees. 

* * * * * 

(c) * * * 

(16) Advisory Committee for 

Pharmaceutical Science and Clinical 

Pharmacology. 

(i) * * * 

(ii) Function: The committee shall 

provide advice on scientific, clinical 

and technical issues related to safety 

and effectiveness of drug products for 

use in the treatment of a broad spectrum 

of human diseases, the quality 

characteristics which such drugs 

purport or are represented to have and 

as required, any other product for which 

the Food and Drug Administration has 

regulatory responsibility, and make 

appropriate recommendations to the 

Commissioner of Food and Drugs. The 

Committee may also review agency 

sponsored intramural and extramural 

biomedical research programs in 

support of FDA’s drug regulatory 

responsibilities and its critical path 

initiatives related to improving the 

efficacy and safety of drugs and 

improving the efficiency of drug 

development. 

* * * * * 

Dated: February 26, 2007. 

Randall W. Lutter, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E7–3716 Filed 3–2–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

44 CFR Part 67 

[Docket No. FEMA–B–7456] 

Withdrawal of Final Flood Elevation 

Determination for Lexington/Fayette 

County, Kentucky and Incorporated 

Areas 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Final rule; withdrawal. 

SUMMARY: The Federal Emergency 

Management Agency (FEMA) withdraws 

the final flood elevation determination 

published in 71 FR 60865, October 17, 

2006 for the Lexington/Fayette County, 

Kentucky and Incorporated Areas, 

hereafter referred to as ‘‘LFC’’. A final 

flood elevation determination will be 

made at a later date. 

DATES: Effective Date: This rule is 

effective March 5, 2007. 

FOR FURTHER INFORMATION CONTACT: 

William R. Blanton, Jr., Engineering 

Management Section, Mitigation 

Division, Federal Emergency 

Management Agency, 500 C Street, SW., 

Washington, DC 20472, (202) 646–3151. 

SUPPLEMENTARY INFORMATION: On July 

17, 2006, FEMA issued a letter to LFC 

finalizing the flood elevation 

determinations. In addition, the July 17, 

2006 letter established a January 17, 

2007 effective date for the Flood 

Insurance Study (FIS) and Flood 

Insurance Rate Map (FIRM) for the 

listed community. The reason for this 

rescission is to allow FEMA to complete 

a thorough review and revision of the 

preliminary maps in light of recent 

identification of potential errors in the 

FIRMs. Contradictions have been 

identified in some areas between the 

printed maps and the digital data base 

that supports the maps. There are also 

questions concerning the locations of 

stream cross sections on the maps. 

These discrepancies could lead to 

incorrect interpretation of the flood risk 

portrayed in the maps, or even incorrect 

flood insurance determinations. Due to 

these issues, it is prudent for FEMA to 

complete a review and revision of these 

maps prior to them becoming effective. 

Until FEMA completes their review 

and revision of the aforementioned 

FIRMs, and digital data base, the final 

flood elevation published in 71 FR 

60865, October 17, 2006 for the listed 

community is hereby withdrawn in 

accordance with section 110 of the 

Flood Disaster Protection Act of 1973, 

42 U.S.C. 4104. Until further notice, the 

release of the FIS and FIRM for the 

listed communities has been postponed. 

National Environmental Policy Act 

This rule is categorically excluded 

from the requirements of 44 CFR part 

10, Environmental Consideration. No 

environmental impact assessment has 

been prepared. 

Regulatory Flexibility Act 

As flood elevation determinations are 

not within the scope of the Regulatory 

Flexibility Act, 5 U.S.C. 601–612, a 

regulatory flexibility analysis is not 

required. 

Regulatory Classification 

This final rule is not a significant 

regulatory action under the criteria of 

section 3(f) of Executive Order 12866 of 

September 30, 1993, Regulatory 

Planning and Review, 58 FR 51735. 

Executive Order 13132, Federalism 

This rule involves no policies that 

have federalism implications under 

Executive Order 13132. 

Executive Order 12988, Civil Justice 

Reform 

This rule meets the applicable 

standards of Executive Order 12988. 

List of Subjects in 44 CFR Part 67 

Administrative practice and 

procedure, Flood insurance, Reporting 

and recordkeeping requirements. 

■ Accordingly, 44 CFR part 67 is 

amended as follows: 

PART 67—[AMENDED] 

■ 1. The authority citation for part 67 

continues to read as follows: 

Authority: 42 U.S.C. 4001 et seq.; 

Reorganization Plan No. 3 of 1978, 3 CFR, 

1978 Comp., p. 329; E.O. 12127, 44 FR 19367, 

3 CFR, 1979 Comp., p. 376. 

§ 67.11 [Amended] 

■ 2. The tables published under the 

authority of § 67.11 are amended to 

withdraw the following: 

The final flood elevation 

determination published in 71 FR 

60865, October 17, 2006 for the 

Lexington/Fayette County, Kentucky 

and Incorporated Areas. 


erjones on PRODPC74 with RULES